KR101982697B1 - Antimicrobial components - Google Patents
Antimicrobial components Download PDFInfo
- Publication number
- KR101982697B1 KR101982697B1 KR1020180141666A KR20180141666A KR101982697B1 KR 101982697 B1 KR101982697 B1 KR 101982697B1 KR 1020180141666 A KR1020180141666 A KR 1020180141666A KR 20180141666 A KR20180141666 A KR 20180141666A KR 101982697 B1 KR101982697 B1 KR 101982697B1
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- weight
- parts
- antimicrobial
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 38
- 239000000341 volatile oil Substances 0.000 claims abstract description 29
- 239000003921 oil Substances 0.000 claims abstract description 22
- 235000019198 oils Nutrition 0.000 claims abstract description 22
- 239000010630 cinnamon oil Substances 0.000 claims abstract description 15
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 13
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 13
- 239000010668 rosemary oil Substances 0.000 claims abstract description 13
- 229940058206 rosemary oil Drugs 0.000 claims abstract description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 239000000344 soap Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 239000010643 fennel seed oil Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 8
- 239000010677 tea tree oil Substances 0.000 claims description 8
- 229940111630 tea tree oil Drugs 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 7
- 239000010642 eucalyptus oil Substances 0.000 claims description 7
- 229940044949 eucalyptus oil Drugs 0.000 claims description 7
- 239000000419 plant extract Substances 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 6
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- 235000019501 Lemon oil Nutrition 0.000 claims description 6
- 241000218378 Magnolia Species 0.000 claims description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 6
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- 239000003240 coconut oil Substances 0.000 claims description 6
- 235000019864 coconut oil Nutrition 0.000 claims description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
- 239000010501 lemon oil Substances 0.000 claims description 6
- 229940041616 menthol Drugs 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 6
- 239000010651 grapefruit oil Substances 0.000 claims description 5
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 5
- 229940092258 rosemary extract Drugs 0.000 claims description 5
- 235000020748 rosemary extract Nutrition 0.000 claims description 5
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 5
- 239000009637 wintergreen oil Substances 0.000 claims description 5
- 244000028419 Styrax benzoin Species 0.000 claims description 3
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 3
- 235000008411 Sumatra benzointree Nutrition 0.000 claims description 3
- 229960002130 benzoin Drugs 0.000 claims description 3
- 235000019382 gum benzoic Nutrition 0.000 claims description 3
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 3
- 239000010665 pine oil Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 2
- 239000010931 gold Substances 0.000 claims 2
- 229910052737 gold Inorganic materials 0.000 claims 2
- 239000010644 fenugreek oil Substances 0.000 claims 1
- 229930013686 lignan Natural products 0.000 claims 1
- 150000005692 lignans Chemical class 0.000 claims 1
- 235000009408 lignans Nutrition 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 abstract description 11
- 201000004647 tinea pedis Diseases 0.000 abstract description 10
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 abstract description 8
- 235000005976 Citrus sinensis Nutrition 0.000 abstract description 6
- 240000002319 Citrus sinensis Species 0.000 abstract description 6
- 239000004599 antimicrobial Substances 0.000 abstract description 6
- 239000010502 orange oil Substances 0.000 abstract description 6
- 241000223238 Trichophyton Species 0.000 abstract description 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 18
- 241000233866 Fungi Species 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 239000006210 lotion Substances 0.000 description 11
- 239000002453 shampoo Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 230000002000 scavenging effect Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 244000053095 fungal pathogen Species 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 208000002474 Tinea Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 241001480043 Arthrodermataceae Species 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000037304 dermatophytes Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- 210000000282 nail Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 244000166675 Cymbopogon nardus Species 0.000 description 3
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 229930007050 cineol Natural products 0.000 description 3
- 229960005233 cineole Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 244000068485 Convallaria majalis Species 0.000 description 2
- 235000009046 Convallaria majalis Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000007163 Dermatomycoses Diseases 0.000 description 2
- 235000000836 Epigaea repens Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 210000000078 claw Anatomy 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 201000003929 dermatomycosis Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- CNGYZEMWVAWWOB-VAWYXSNFSA-N 5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound N=1C(NC=2C=C(C(\C=C\C=3C(=CC(NC=4N=C(N=C(NC=5C=CC=CC=5)N=4)N(CCO)CCO)=CC=3)S(O)(=O)=O)=CC=2)S(O)(=O)=O)=NC(N(CCO)CCO)=NC=1NC1=CC=CC=C1 CNGYZEMWVAWWOB-VAWYXSNFSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- -1 elixirs Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229910000078 germane Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D34/00—Containers or accessories specially adapted for handling liquid toiletry or cosmetic substances, e.g. perfumes
- A45D34/04—Appliances specially adapted for applying liquid, e.g. using roller or ball
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 식물 정유를 포함하는 항균제 조성물에 관한 것으로서, 보다 상세하게는 회향유, 계피유, 페파민트유, 로즈마리유, 스윗오렌지유를 포함하는 항균정유(식물정유)를 포함하여 이루어짐에 따라 백선균, 즉 무좀균과 대장균에 대한 항균 효과가 뛰어난 식물정유를 포함하는 항균제 조성물에 관한 것이다.The present invention relates to an antimicrobial composition comprising a plant essential oil, and more particularly, to an antimicrobial composition comprising a fungicidal composition comprising fecal oil, cinnamon oil, peppermint oil, rosemary oil and sweet orange oil, And a plant essential oil excellent in antimicrobial effect against E. coli.
진균(곰팡이)에 의해 발생되는 발생되는 피부질환을 총칭하여 피부진균증(derma-tomycosis)이라 한다. 특히 피부의 각질, 모발, 손톱, 발톱 등의 각질조직에 침입하여 기생하는 피부사상균(dermatophyte)에 의해 발생되는 경우를 피부사상균증(derma-tophytosis), 백선(Tinea) 또는 표재성진균증(superficial fungal infection)이라고 한다.(Ribbon, J. W.(1998) Medical Mycology. In The pathogenic fungi and the pathogenic actinomyces. 2nd Ed. W.B.Saunders Comoany. Philadelphia, London, toronto.)Skin diseases caused by fungi (fungus) are collectively referred to as derma-tomycosis. (Dermatophyte), Tinea or Superficial fungal infection, which is caused by parasitic dermatophyte penetrating into keratin tissues such as keratin, hairs, nails and claws of skin, (Ribbon, JW (1998) Medical Mycology. In The pathogenic fungi and the pathogenic actinomyces., 2nd ed. WBSaunders Comoany. Philadelphia, London, toronto.)
표재성진균증은 피부 침입부위에 따라 발생부위가 손과 발인 경우 수족족부백선(Tinea manus Tinea pedis), 얼굴인 경우 안면부백선(Tinea faciale), 두부의 경우에는 두부백선(Tinea capitis), 서혜부(사타구니)에 발생했을 때에는 완선(Tinea crusis), 손톱과 발톱의 경우에는 조갑백선(Tinea ungium 또는 Onychomy-cosis), 상기 부위를 제외한 곳에 발생한 경우를 체부백선(Tinea corporis)이라고 부른다.(Rezab다, G.H. and Friedman, A.D. 1992. Drugs 43(5): 674-682. : Kamalam, A. and Thambiah, A.S. 1976. Sabouraudia 14(2): 129-148).In case of superficial fungus, Tinea manus Tinea pedis in case of hands and feet, Tinea faciale in case of face, Tinea capitis in case of tofu, Tinea crusis in case of nails and toenails, Tinea ungium or Onychomy-cosis in case of nails and claws, and Tinea corporis in cases where it is excluded. (Rezab da GH and Friedman, AD 1992. Drugs 43 (5): 674-682.: Kamalam, A. and Thambiah, AS 1976. Sabouraudia 14 (2): 129-148).
표재성 진균증의 주된 원인은 소아포균(microsporum), 표피균(epidermo-phyton), 백색균(Trichophyton), 칸디다균(candida species), 이다. 특히 백색균은 피부, 체모, 조갑 모두를 침입할 수 있는 특성을 가지고 있다.(Weitzman, I. and Summerbell, R.C. 1995. The dermatophytes. Clinical Microbiology Rewiews 8(2): 240-259)The main causes of superficial mycoses are microsporum, epidermo-phyton, Trichophyton, and candida species. In particular, white fungi have the property of invading both skin, hair, and nail (Weitzman, I. and Summerbell, R.C. 1995. The dermatophytes. Clinical Microbiology Rewiews 8 (2): 240-259)
표재성 진균증의 원인균들은 상피세포 상부의 각질조직(keratin)에 기생히여 번식함으로써 표재성 병변을 유발하지만, 때때로 상피 상부이하까지도 염증을 유발할 수도 있고, 백선진(Dermatophytid)을 일으키기도 한다.The causative organisms of superficial fungi are parasitic on the keratin of the upper part of the epithelium and cause superficial lesions. Sometimes, they may cause inflammation even below the epithelium and cause dermatophytidosis.
병원성 곰팡이는 전 세계적으로 분포하며, 사람을 포함한 동물에 질병을 유발한다. 병원성 곰팡이는 항상 접촉에 의해 병을 유발시키는 것이 아니고, 감염 곰팡이의 종류, 숙주의 나이, 면역상태, 합병증 유무, 피부 건강도, 영양이나, 호르몬 상태에 따라 감염여부가 달리 나타난다. (Brasch, J. and Gottehaskamp, D. 1992. The effect of selected human steroid hormones upon the growth of dermatophytes with different adaptation to man. Mycopathologia 120(2); 87-92)Pathogenic fungi are distributed throughout the world and cause diseases in animals, including humans. The pathogenic fungus does not always cause disease by contact, but it varies depending on the type of infecting fungus, the age of host, immune status, complications, skin health, nutrition, and hormone status. (Brasch, J. and Gottehaskamp, D. 1992. The effect of selected human steroid hormones on the growth of dermatophytes with different adaptation to man. Mycopathologia 120 (2); 87-92)
대다수의 더마토파이트 속(Dermatophyte spp) 곰팡이에 의한 피부 및 그 부속기 감염을 피부 사상균증(윤선)이라고 한다. 이러한 곰팡이 그룹들은 표피 각화층에 국한되어 서싣하며, 일부 종들은 동물 조직 내에 침투하여 서식하기도 한다. 편의상 숙주에 따라, 엔트로필릭(Anthrophillic, 사람 기생), 주필릭(Zoophillic, 동물 기생), 지오필릭(토양내에 기생하는 saprophyte)라 한다. (Gupta, A.K., Einarson, T.R., Summerbell,R.C. and Shear, N.H. 1998. A North American perspective of Drug. 55(5): 645-674)Dermatophyte spp in the vast majority of the skin and its appendage infections caused by the fungus is called dermatophytosis. These fungi groups are localized to the epidermal keratinization layer, and some species invade and live in animal tissues. For convenience, it is called anthrophillic, zoophillic, and geophilic (saprophyte in the soil), depending on the host. (Gupta, A. K., Einarson, T. R., Summerbell, R. C. and Shear, N. H. 1998. A North American perspective of Drug. 55 (5): 645-674)
표재성 진균증의 치료는 원칙적으로 국소 및 전신의 항진균제 사용으로 이루어지며, 경우에 따라 각질 용해제의 도포를 병행하여 실시된다. 증상 및 피부병변이 소실된 후에도 약 2-4주간 치료가 요구된다. 그러나 족부백선의 경우, 환자의 부주의나 신체부위의 특성 및 면역 결핍성으로 인하여 치료에 실패하거나 재발할 가능성이 높다.Treatment of superficial mycoses is based on the use of topical and systemic antifungal agents and, in some cases, application of the keratolytic agent is carried out in parallel. After symptoms and skin lesions have disappeared, treatment for about 2-4 weeks is required. However, in the case of tinea pedis, it is highly likely that the patient will fail or recur due to the carelessness, the characteristics of the body part and the immunodeficiency.
지금까지 많은 항진균제들이 피부진균증을 치료하기 위해 이용되어 왔으나, 재발비율이 높고 피부독성에 대한 인식 증가로 인해 보다 안전하고 우수한 항균물질을 천연물에서 찾으려는 노력이 이루어지고 있다.So far, many antifungal agents have been used to treat skin fungi, but efforts have been made to find more safe and better antimicrobial substances in natural products due to the high recurrence rate and increased recognition of skin toxicity.
따라서 본 발명은 상기 문제를 해결하기 위해 안출한 것으로서,SUMMARY OF THE INVENTION Accordingly, the present invention has been made keeping in mind the above problems occurring in the prior art,
회향유, 계피유, 페파민트유, 로즈마리유, 스윗오렌지유를 포함하여 이루어짐에 따라 진균, 백선균 또는 대장균에 대하여 항균활성을 가지며, 천연 식물정유를 사용함에 따라 피부에 무해하고 친환경적인 항균제 조성물을 제공함을 목적으로 한다.It is an object of the present invention to provide an antimicrobial composition which is harmless to the skin and which is environmentally friendly as it contains fennel oil, cinnamon oil, peppermint oil, rosemary oil and sweet orange oil and has antimicrobial activity against fungi, .
또한 정제수, 코코넛유, 포타슘하이드록사이드, 피마자유, 올리브유, 송진, 설탕, 황금추출물, 목련추출물, 멘톨 등을 더 포함함에 따라 생분해되어 친환경적이며, 항균기능, 간지러움, 갈라짐, 습진 등의 종합적인 문제를 해결할 수 있으며,It is biodegradable by further containing purified water, coconut oil, potassium hydroxide, castor oil, olive oil, rosin, sugar, golden extract, magnolia extract and menthol. It is eco-friendly and has a comprehensive antibacterial function such as antibacterial function, tickling, cracking, You can fix the problem,
탈취에 효과적인 유가 함유되어, 악취의 원인을 해결하고, 잔향을 남길 수 있는 항균제 조성물을 제공함을 목적으로 한다.It is an object of the present invention to provide an antimicrobial composition which contains an oil effective for deodorization and can solve the cause of odor and leave a reverberation.
상기와 같은 목적을 달성하기 위하여, 본 발명에 따른 항균제 조성물은In order to achieve the above object, the antimicrobial composition according to the present invention comprises
항균제 조성물을 100중량부로 할 때,When the antibacterial agent composition is used in an amount of 100 parts by weight,
계피유 5~6 중량부, 회향유 0.2~0.3 중량부, 페파민트유 5~6 중량부, 로즈마리유 0.2~0.3 중량부를 포함하는 항균정유를 포함하여 이루어지는 것을 특징으로 한다.5 to 6 parts by weight of cinnamon oil, 0.2 to 0.3 parts by weight of fennel oil, 5 to 6 parts by weight of peppermint oil, and 0.2 to 0.3 parts by weight of rosemary oil.
이상과 같이 본 발명에 따른 항균제 조성물은As described above, the antibacterial agent composition according to the present invention comprises
계피유, 회향유, 페파민트유, 로즈마리유, 스윗오렌지유를 이용하여 백선균 및 대장균에 대하여 매우 강한 항균활성을 가져, 무좀 등을 쉽게 치료할 수 있으며,It has a very strong antimicrobial activity against Pseudomonas aeruginosa and Escherichia coli by using cinnamon oil, fennel oil, peppermint oil, rosemary oil, sweet orange oil,
천연 식물유를 사용함에 따라 독성이 없어 피부에 무해하고, 세척 후 물에 생분해되어, 친환경적이라는 효과가 있다.By using natural vegetable oil, it is harmless to the skin because it is not toxic, and it is biodegraded in water after washing, and it is eco-friendly.
특히, 항균, 항염, 항바이러스 성분의 에센셜 유와 송진을 더 함유하고, 식물유를 비누화한 순비누를 더 포함하여 헹굼이 빠르고 보습과 깨끗한 사용감이 있으며, 합성계면활성제를 사용하지 않아 물에 생분해되어 친환경적인 특징이 있다.Especially, it contains more essential soap which contains essential oil and rosin of antibacterial, anti-inflammatory and antiviral ingredients and contains soaped vegetable oil so that rinse is quick and moisturizing and clean feeling is used. It does not use synthetic surfactant, .
각종 천연유를 핸드메이드 방식으로 비누화하여 사용함에 따라 빠른 헹굼과 보습력이 우수하고 친환경적이며,Handmade saponification of various natural oils to provide quick rinsing and moisturizing, eco-friendly,
탈취에 효과적인 유를 함유함에 따라 악취의 원인을 제거하고 자연스러운 잔향으로 상쾌하게 발을 관리할 수 있는 효과가 있다.Since it contains oil that is effective for deodorization, it is possible to eliminate the cause of odor and to manage the feet with a refreshing reverberation with natural reverberation.
나아가 상기 조성물을 이용하여 제조된 항균 로션제를 보관하는 보관용기에 쓸어내림수단이 더 구비됨에 따라 내부에 충진되는 로션제를 알뜰하고 경제적으로 사용할 수 있는 효과가 있다.Furthermore, since the anti-bacterial lotion manufactured using the above-mentioned composition can be stored in a storage container for storing the anti-bacterial lotion agent, the lotion agent to be filled in the inside can be cleaned and economically used.
도 1은 본 발명에 따른 항균제 조성물의 성분표
도 2는 본 발명에 따른 항균제 조성물을 이용하여 제조된 항균 로션제의 보관용기Fig. 1 is a table showing the composition of the antimicrobial composition according to the present invention
FIG. 2 is a view showing a container for an antimicrobial lotion prepared using the antibacterial composition according to the present invention
이하 첨부된 도면을 참고하여 본 발명을 상세히 설명하도록 한다. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will now be described in detail with reference to the accompanying drawings.
본 발명은 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있는 바, 구현예(態樣, aspect)(또는 실시예)들을 본문에 상세하게 설명하고자 한다. 그러나 이는 본 발명을 특정한 개시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. While the present invention has been described in connection with certain embodiments, it is obvious that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. It is to be understood, however, that the invention is not intended to be limited to the particular forms disclosed, but on the contrary, is intended to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
각 도면에서 동일한 참조부호, 특히 십의 자리 및 일의 자리 수, 또는 십의 자리, 일의 자리 및 알파벳이 동일한 참조부호는 동일 또는 유사한 기능을 갖는 부재를 나타내고, 특별한 언급이 없을 경우 도면의 각 참조부호가 지칭하는 부재는 이러한 기준에 준하는 부재로 파악하면 된다.In the drawings, the same reference numerals are used for the same reference numerals, and in particular, the numerals of the tens and the digits of the digits, the digits of the tens, the digits of the digits and the alphabets are the same, Members referred to by reference numerals can be identified as members corresponding to these standards.
또 각 도면에서 구성요소들은 이해의 편의 등을 고려하여 크기나 두께를 과장되게 크거나(또는 두껍게) 작게(또는 얇게) 표현하거나, 단순화하여 표현하고 있으나 이에 의하여 본 발명의 보호범위가 제한적으로 해석되어서는 안 된다.In the drawings, the components are expressed by exaggeratingly larger (or thicker) or smaller (or thinner) in size or thickness in consideration of the convenience of understanding, etc. However, It should not be.
본 명세서에서 사용한 용어는 단지 특정한 구현예(태양, 態樣, aspect)(또는 실시예)를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, ~포함하다~ 또는 ~이루어진다~ 등의 용어는 명세서 상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The singular expressions include plural expressions unless the context clearly dictates otherwise. In the present application, the term " comprising " or " consisting of ", or the like, refers to the presence of a feature, a number, a step, an operation, an element, a component, But do not preclude the presence or addition of one or more other features, integers, steps, operations, components, parts, or combinations thereof.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless defined otherwise, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Terms such as those defined in commonly used dictionaries are to be interpreted as having a meaning consistent with the contextual meaning of the related art and are to be interpreted as either ideal or overly formal in the sense of the present application Do not.
본 발명에 따른 항균제 조성물은 전체 중량부를 100중량부로 할 때,When the total weight of the antibacterial agent composition according to the present invention is 100 parts by weight,
계피유 5~6 중량부, 회향유 0.2~0.3 중량부, 페파민트유 5~6 중량부, 로즈마리유 0.2~0.3 중량부를 포함하여 이루어지며, 그레이프후르츠유 7~8 중량부, 유칼립투스유 3~4 중량부, 티트리유 1~2 중량부를 포함하는 항균정유(식물정유)를 포함하여 이루어지는 것을 특징으로 한다.5 to 6 parts by weight of cinnamon oil, 0.2 to 0.3 parts by weight of fennel oil, 5 to 6 parts by weight of peppermint oil and 0.2 to 0.3 part by weight of rosemary oil, wherein 7 to 8 parts by weight of grapefruit oil, 3 to 4 parts by weight of eucalyptus oil , And 1 to 2 parts by weight of tea tree oil (plant essential oil).
보다 정확하게는 도 1에 도시된 바와 같이, 계피유 5.14중량부, 회향유 0.26중량부, 페퍼민트유 5.14중량부, 로즈마리유 0.26중량부, 유칼립투스유 3.6중량부, 티트리유 1.54중량부로 이루어지는 것이 바람직하며,More precisely, it is preferable that 5.14 parts by weight of cinnamon oil, 0.26 parts by weight of fennel oil, 5.14 parts by weight of peppermint oil, 0.26 parts by weight of rosemary oil, 3.6 parts by weight of eucalyptus oil and 1.54 parts by weight of tea tree oil,
레몬유 2~3 중량부, 보다 바람직하게는 2.57 중량부를 더 포함하는 것이 좋다.2 to 3 parts by weight, more preferably 2.57 parts by weight, of lemon oil.
또한 스윗오렌지유를 더 포함하는 것도 가능하다.It is also possible to include sweet orange oil.
상기 항균정유(식물정유)에 대하여 살펴보면,As for the antibacterial essential oil (plant essential oil)
계피유는 계피의 주성분을 이루고 있는 정유로서, Cinnamic aldehyde, Camphene, Cineol, Linalool, Eugenol 이며,Cinnamon oil is the essential oil which is the main component of cinnamon, Cinnamic aldehyde, Camphene, Cineol, Linalool, Eugenol,
상기 Cinnamic aldehyde는 계피유의 주요 성분인 노란색의 유동성 액체이고,Cinnamic aldehyde is a yellow liquid fluid which is a major component of cinnamon oil,
상기 Camphene는 테르펜류에 속하는 불포화탄화수소로 무색의 결정을 띠며 장뇌의 합성이나 향료의 원료로 쓰이고,The Camphene is an unsaturated hydrocarbon belonging to terpenes and has colorless crystals and is used as a source of camphor synthesis and fragrance,
상기 Cineol는 무색 액체의 천연 유기화합물로 신선한 장뇌(camphor)와 같은 냄새와 향긋한 향, 시원한 맛을 가지고 있다.Cineol is a colorless liquid natural organic compound with fresh camphor-like odor, fragrant flavor and cool taste.
이러한 계피유의 효능으로는 대표적으로 항균효과를 들 수 있어, The efficacy of such cinnamon oil is representative of its antibacterial effect,
항생제처럼 해로운 세균을 없애주는 효능이 탁월하고, 충치 예방에 흔히 활용, 계피 용액 반 숟갈을 따뜻한 물에 타서 양치질하면 충치균, 입냄새 모두 없앨 수 있다.It is very effective in eliminating harmful bacteria like antibiotics. It is widely used for prevention of tooth decay. If you take half of a solution of cinnamon in warm water and brush it, you can eliminate all the bacteria and bad breath.
또한 곰팡이를 제거하는 데 사용되기도 한다.It is also used to remove mold.
회향유는 Fennel 유로서, 여성호르몬(에스트로겐)과 유사한 식물성 호르몬 함유하여서 갱년기 장애 증상 완화, 모유 생성 촉진, 소량 월경을 정상화 시키는데 도움을 준다. 또한 항박테리아. 항균 및 거담 작용 으로 기관지염. 감기, 기침 등에 도움을 주고(방향. 흡입), 우수한 신체 정화 작용으로 과음, 과식으로 생긴 독소를 제거해주며, 스트레스성 소화 불량, 헛배 부름, 구토증. 대장염 등에 좋으며, 또한 간장, 신장, 비장의 강장 작용으로 숙취 해소에 많은 보탬이 된다. 이뇨작용이 있어 비뇨기 감염, 신장 결석, 셀룰라이트 해소 등에 사용되기도 하며, 해독 작용으로 벌레 물린데, 뱀에 물린 독을 제거할 수 있는 특징이 있다.Fennel oil is a Fennel oil containing a vegetable hormone similar to female hormone (estrogen) to help alleviate menopausal symptoms, promote breast milk production, and normalize small amounts of menstruation. Also antibacterial. Bronchitis caused by antibacterial and germane action. Helps with colds and coughs (direction and suction), excellent body cleansing action, eliminates overeating and overeating toxins, stressful indigestion, flatulence, vomiting. It is also good for colitis, and it is also a great addition to the relief of hangover by the action of the liver, kidney, and spleen. It is also used for urinary infection, kidney stones, and cellulite removal due to its diuretic effect. It has a characteristic that it can remove insect bites from snake bites due to detoxification.
레몬유는 비타민C와 구연산을 다량 함유하며, 항균작용이 있어 식중독균을 살균할 수 있고, 각종 세균에 대한 저항력을 높일 수 있는 특징이 있다.Lemon oil contains a large amount of vitamin C and citric acid. It has antimicrobial action, which can sterilize food poisoning bacteria and increase the resistance to various bacteria.
페퍼민트유는 진통효과와 항균작용 효과가 있는 정유로서, 유해세균을 줄여주고 통증완화에 효과가 있다.Peppermint oil is an essential oil with analgesic and antimicrobial effects, which reduces harmful bacteria and is effective in relieving pain.
그레이프후르츠유는 흔히 자몽을 뜻하는 것으로서, 레몬유와 마찬가지로 비타민C와 구연산을 다량 함유하여 항균작용에 뛰어나다는 특징이 있다.Grapefruit oil often refers to grapefruit, which, like lemon oil, contains a large amount of vitamin C and citric acid.
로즈마리유는 로스마린 산을 주성분으로 하여 항균 작용과 항 바이러스 작용이 있다. 꽃가루 알레르기의 증상도 완화시켜주고, 로즈마리 유 트리트먼트로 사용하여 비듬이 방지되고, 두피의 혈액 순환을 활성화시켜 발모에도 효과가 있다. 또한 항 경련 작용도 있어 기관지 경련을 억제하고 호흡하기 쉽게 하며, 방충효과 또한 기대할 수 있다.Rosemary oil has antimicrobial activity and antiviral activity mainly based on rosmarinic acid. It also alleviates the symptoms of pollen allergies. It is also used as a rosemary oil treatment to prevent dandruff, and it also has an effect on hair growth by activating blood circulation in the scalp. It also has anticonvulsant action, which makes it easier to suppress bronchospasm, to breathe easily, and to antimicrobial effects.
유칼립투스유는 시네올 성분을 다량 함유하고 있으며, 이로인해 강력한 살균, 소염, 방부작용을 한다.Eucalyptus oil contains a large amount of cineol, which results in strong sterilization, anti-inflammation, and side effects.
티트리유는 방부성, 항균성, 항염, 면역강화, 상충효과 등 특히 항 바이러스 효과가 뛰어난 것으로 알려져 있으며, 면역력을 향상 시켜주고, 독소를 배출하는데 도움을 주며, 기관지염, 감기 바이러스 제거에 효과적이고, 항 박테리아, 항균, 염증이나 곰팡이균에 탁월하여 여드름 등의 피부 트러블에 사용된다.Tea tree oil has been known to have excellent antiviral effects such as antiseptic, antimicrobial, anti-inflammatory, immune strengthening, and conflicting effects. It is known to improve immunity, helps to release toxins, is effective in eliminating bronchitis and cold virus, It is excellent for bacteria, antibacterial, inflammation and fungus bacteria and is used for skin troubles such as acne.
상기와 같이 본 출원인은 회향유, 계피유, 페퍼민트유, 로즈마리유, 스윗 오렌지유가 항균 활성을 가짐을 확인하고, 이에 따라 본 발명에 따른 항균제 조성물을 배합하였다.As described above, the present applicant confirmed that antifungal oil, cinnamon oil, peppermint oil, rosemary oil, and sweet orange oil have antimicrobial activity, and thus the antimicrobial composition according to the present invention was formulated.
나아가 정제수, 순비누, 식물추출첨가물과, 상기 항균정유(에센셜오일)에 추가적인 식물정유를 더 함유하도록 배합함에 따라, 화학적 계면활성제를 사용하지 않음으로서 피부에 저자극적이고, 환경친화적으로 세정효과를 극대화 할 수 있다.Furthermore, by adding the purified water, the net soap, the plant extract additive, and the additional essential essential oil to the above-mentioned antimicrobial essential oil (essential oil), the use of the chemical surfactant is not used so that the skin is hypoallergenic, Can be maximized.
구체적으로 정제수는 물에 함유되어 있는 용해된 이온, 고체입자, 미생물, 유기물 및 용해된 기체류 등 도펜트를 완벽하게 제거하여 만든 순수한 물을 말한다.Specifically, purified water refers to pure water formed by completely removing the penta from dissolved ions, solid particles, microorganisms, organic substances, and dissolved gas residues contained in water.
순비누는 식물성유지 등을 포함하며, 화학향료, 색소, 소다, 안전제, 형광증백제 등이 들어가지 않은 비누를 말하며, 본 발명에서의 순비누는 고형화되지 않은 액상비누로 이루어져, 상기 식물추출첨가물, 항균정유 등을 함유할 수 있도록 구성된다.The net soap includes vegetable oil and the like and refers to a soap which does not contain a chemical perfume, a pigment, a soda, a safety agent, a fluorescent brightener, etc. The net soap in the present invention is composed of a liquid soap which is not solidified, Additives, antimicrobial essential oils, and the like.
순비누는 코코넛유, 포타슘하이드록사이드, 피마자유, 올리브유 및 설탕을 포함하여 이루어진다.The net soap comprises coconut oil, potassium hydroxide, castor oil, olive oil and sugar.
각각의 배합비를 살펴보면,Looking at the blending ratio of each,
정제수는 50~60 중량부, 순비누 20~22 중량부, 식물추출첨가물 0.9~1.0 중량부, 항균정유 25~26 중량부로 이루어지며, 이 때 상기 항균정유는 상기 계피유, 회향유, 페파민트유, 로즈마리유, 그레이프후르츠유, 유칼립투스유, 티트리유를 포함하는 것으로 한다.Wherein the purified water comprises 50 to 60 parts by weight of pure soap, 20 to 22 parts by weight of pure soap, 0.9 to 1.0 part by weight of a plant extract additive, and 25 to 26 parts by weight of an antibacterial essential oil, wherein the antimicrobial essential oil is selected from the group consisting of cinnamon oil, fennel oil, Grapefruit oil, eucalyptus oil, and tea tree oil.
더욱 바람직하게는 하기 실시예를 바탕으로, 정제수 52.48 중량부, 순비누 20.66 중량부, 식물추출첨가물 0.93 중량부, 항균정유 25.93 중량부로 이루어진다.More preferably, based on the following examples, purified water 52.48 parts by weight, net soap 20.66 parts by weight, plant extract additive 0.93 parts by weight, and antibacterial essential oil 25.93 parts by weight.
상기 순비누는 코코넛유 10~12 중량부, 포타슘하이드록사이드 3~4 중량부, 피마자유 2~3 중량부, 올리브유 1~2 중량부, 설탕 1~2 중량부로 이루어지고,Wherein the net soap comprises 10 to 12 parts by weight of coconut oil, 3 to 4 parts by weight of potassium hydroxide, 2 to 3 parts by weight of castor oil, 1 to 2 parts by weight of olive oil, and 1 to 2 parts by weight of sugar,
더욱 정확하게는 코코넛유 11.06 중량부, 포타슘하이드록사이드 3.69 중량부, 피마자유 2.57 중량부, 올리브유 1.8 중량부, 설탕 1.54 중량부로 이루어진다.More precisely, it comprises 11.06 parts by weight of coconut oil, 3.69 parts by weight of potassium hydroxide, 2.57 parts by weight of castor oil, 1.8 parts by weight of olive oil, and 1.54 parts by weight of sugar.
상기 식물추출첨가물은 송진, 황금추출물, 로즈마리추출물, 목련추출물(목련가지, 꽃, 잎 추출물을 말한다.) 멘톨로 이루어지며, 이 때 각각의 중량부는 송진 0.05~0.15 중량부, 황금추출물 0.15~0.25 중량부, 로즈마리추출물 0.15~0.25 중량부, 목련추출물 0.15~0.25 중량부, 멘톨 0.15~0.25 중량부로 이루어지고, 더욱 정확하게는 송진 0.1 중량부, 황금추출물 0.21 중량부, 로즈마리추출물 0.21 중량부, 목련추출물 0.21 중량부, 멘톨 0.21 중량부로 이루어진다.The plant extract additive is composed of rosin, a golden extract, a rosemary extract, a magnolia extract (referred to as Magnolia japonica, flower, leaf extract) menthol, each of which contains 0.05-0.15 parts by weight of rosin, 0.15-0.25 0.15 to 0.25 parts by weight of a rosemary extract, 0.15 to 0.25 parts by weight of a magnolia extract, and 0.15 to 0.25 parts by weight of menthol. More specifically, 0.1 part by weight of pine root, 0.21 part by weight of a golden extract, 0.21 part by weight of a rosemary extract, 0.21 parts by weight, and menthol 0.21 parts by weight.
상기 항균정유는 씨트로넬라유, 티트리유, 메이창유, 라벤더유, 윈터그린유, 벤조인유, 패출리유를 더 함유하여 이루어지는 것으로서, 각각의 조성비는 씨트로넬라유 0.05~0.15 중량부, 티트리유와 메이창유는 각각 0.02~0.1 중량부, 라벤더유는 0.02~0.1 중량부, 윈터그린유와 벤조일유와 패출리유는 각각 0.005~0.015 중량부로 이루어지며,The antimicrobial essential oil further contains citronella oil, tea tree oil, mayo oil, lavender oil, wintergreen oil, benzoin oil, and perennial oil. The composition ratio thereof is 0.05 to 0.15 parts by weight of citronella, 0.02 to 0.1 parts by weight of lavender oil, 0.02 to 0.1 part by weight of lavender oil, 0.005 to 0.015 part by weight of wintergreen oil, benzoyl oil and oil extract, respectively,
보다 정확하게는 씨트로넬라유 0.08 중량부, 메이창유는 0.05 중량부, 라벤더유와 파인유는 각각 0.03 중량부, 윈터그린유와 벤조일유와 패출리유는 각각 0.01 중량부로 이루어진다.0.08 parts by weight of citronella, 0.05 parts by weight of Mayflower oil, 0.03 parts by weight of lavender oil and pine oil, and 0.01 part by weight of wintergreen oil, benzoyl oil and patch oil, respectively.
즉, 종합하면, 상기 항균정유는 계피유 5.14중량부, 회향유 0.26중량부, 페퍼민트유 5.14중량부, 로즈마리유 0.26중량부, 유칼립투스유 3.6중량부, 티트리유 1.54중량부, 레몬유 2.57중량부, 그레이프후르츠유 5.14중량부, 씨트로넬라유 0.08 중량부, 메이창유는 0.05 중량부, 라벤더유와 파인유는 각각 0.03 중량부, 윈터그린유와 벤조일유와 패출리유는 각각 0.01 중량부로 이루어지는 것이다.In other words, the antimicrobial essential oil contains 5.14 parts by weight of cinnamon oil, 0.26 parts by weight of fennel oil, 5.14 parts by weight of peppermint oil, 0.26 parts by weight of rosemary oil, 3.6 parts by weight of eucalyptus oil, 1.54 parts by weight of tea tree oil, 2.57 parts by weight of lemon oil, 5.14 parts by weight of fruit flavor, 0.08 part by weight of citronella, 0.05 parts by weight of Mayflower oil, 0.03 part by weight of lavender oil and 0.01 part by weight of each of benzoguanyl oil and phenyle oil.
먼저, 순비누의 구성성분은 하기 [표1]과 같은 효능이 있다.First, the ingredients of net soap have the same efficacy as the following [Table 1].
[표1][Table 1]
상기 식물추출첨가물은 하기 [표2]와 같은 효과가 있다.The plant extract additive has the same effect as the following [Table 2].
[표2][Table 2]
항균정유는 하기[표3]과 같은 효과가 있다.The antibacterial essential oil has the same effect as the following [Table 3].
[표3][Table 3]
하기 [표4]는 각각의 유의 성분을 나타낸 표이다.Table 4 below is a table showing the respective components of the oil.
[표4][Table 4]
또한 본 발명의 항균제 조성물을 통한 정유는 무좀을 유발하는 백선균 및 식중독을 유발하는 대장균에 적용하여 생육 저해환(Clear zone)을 측정한 결과 모두 우수한 항균 활성을 나타냄을 알 수 있었다.(표6 참조)In addition, it was found that the essential oil through the antibacterial composition of the present invention exhibited excellent antimicrobial activity as a result of measuring the clear zone of the pycnogenesis causing athlete's foot and applying Escherichia coli causing food poisoning (see Table 6). )
나아가 본 발명에 따른 항균제 조성물은 병원성 곰팡이 및 세균에 대하여도 생육억제 활성을 가지는 것으로 바람직하게는 백선균 및 대장균에 대하여 생육억제 활성을 가질 수 있다.Furthermore, the antimicrobial composition according to the present invention has growth inhibitory activity against pathogenic fungi and bacteria, and preferably has growth inhibitory activity against pycnotoxins and Escherichia coli.
본 발명의 항균 조성물은 하기 [표 5]에 기재된 병원성 곰팡이 및 세균에 대하여 항균효과를 가진다. 대표적인 병원성 곰팡이는 트리코피톤 루프럼(Trichophyton rubrum, ATCC 28188)이고, 세균은 대장균(E.coli, ATCC 25922)이다.The antimicrobial composition of the present invention has an antimicrobial effect against pathogenic fungi and bacteria described in the following [Table 5]. A representative pathogenic fungus is Trichophyton rubrum (ATCC 28188), and the bacterium is E. coli (ATCC 25922).
[표1][Table 1]
본 발명에 따른 항균제 조성물은 병원성 곰팡이의 생육억제를 위한 용도로 사용할 수 있으며, 바람직하게는 세정제, 무좀 등의 피부진균증(derma-tomycosis) 치료제, 소독제 등으로 사용할 수 있으며, The antimicrobial composition according to the present invention can be used for inhibiting the growth of pathogenic fungi. Preferably, it can be used as a therapeutic agent for skin derma-tomycosis such as a detergent, athlete's foot, disinfectant,
항균제 조성물의 제제로는 경고제, 과립제, 로션제, 리니멘트제(liniments), 리모나데제(limonades), 방향수제, 산제(散濟), 시럽제(syrups), 안연고제, 액제, 에어로솔제, 엑스제(extracts), 엘릭실제(elixier), 연고제로 이용될 수 있으며, 이에 권리범위를 제한 해석해서는 안 된다.Formulations of the antimicrobial composition include, but are not limited to, an anti-inflammatory agent, a granule, a lotion, liniments, limonades, a handmade powder, a syrup, a syrups, an ointment, Extracts, elixirs, ointments, and should not be construed as limiting the scope of its rights.
또한 본 발명의 항균제 조성물은 제제 및 사용방법에 따라 생리약학적으로 허용 가능한 담체를 더 포함할 수 있으며, 항균 조성물 내 정유의 함량은 1 내지 20 중량%가 바람직하다. 항균 조성물의 투여량은 1일 10 내지 50 mg으로 1회 내지 3회 실시하는 것이 바람직하나, 병의 중한 정도 및 환자의 건강상태에 따라 조절하는 것이 더욱 바람직하다.The antimicrobial composition of the present invention may further comprise a physiologically acceptable carrier according to the preparation and the method of use, and the content of the essential oil in the antimicrobial composition is preferably 1 to 20% by weight. The dosage of the antimicrobial composition is preferably 10 to 50 mg per day, preferably 1 to 3 times, more preferably in accordance with the severity of the disease and the health condition of the patient.
실시예. 항균제 조성물의 제조Examples. Preparation of antimicrobial composition
도 1에 나타난 배합비를 토대로 항균제 조성물을 제조하였다.The antimicrobial composition was prepared based on the blending ratio shown in Fig.
실험예1. 곰팡이 및 세균의 생육저해 활성Experimental Example 1 Activity inhibiting the growth of fungi and bacteria
항균제 조성물에 대한 여지당 적정농도를 처리하였을 때, 백선균 1종과 대장균 1종에 대해 보이는 생육저해 활성을 측정하여 하기 [표2]에 나타내었다.The growth inhibitory activity of 1 pseudomonas species and one Escherichia coli was measured when the appropriate concentration of the antimicrobial composition was applied to the leaves, and the results are shown in Table 2 below.
[표2][Table 2]
상기 [표2]를 보면, 생육저해환의 크기가 10mm 이상으로 나타난 경우 곰팡이 및 세균에 생육저해활성을 가지는 것으로 판단할 수 있으며, 2종 모두 100mg과 50mg 처리 시 항균활성이 뛰어남을 알 수 있었다.As shown in Table 2, when the size of the growth inhibition ring is 10 mm or more, it can be judged that the growth inhibitory activity is effective against fungi and bacteria, and both antibiotic activities are excellent when 100 mg and 50 mg are treated.
실험예2.Experimental Example 2
상기 본 발명에 따른 항균제 조성물을 에탄올에 녹여 5%로 제조한 다음 족부가 감염된 5명의 성인 남성을 대상으로 임상실험을 하였다.The antimicrobial composition according to the present invention was dissolved in ethanol to prepare 5% of the antimicrobial composition.
1. 조건 : 식물정유 조성물은 매일 3초 동안 1회 발에 분무하여(식물정유 성분이 0.1g처리된 수준) 무좀균의 진전경과를 시간별로 조사하였다.1. Condition: The plant refinement composition was sprayed on one foot for 3 seconds every day (the level of the plant essential oil was treated with 0.1 g), and the progress of the progress of athrobocyte was examined over time.
2. 결과2. Results
2-1. 무좀이 심한 사람2-1. Athlete's foot
1) 처리 1일 : 갈라지고 습진과 같이 진눌린 상피세포 또는 조직에서 진물이 사라졌다.1) Treatment Day 1: Cracks and eczema have disappeared from the crusted epithelial cells or tissues like eczema.
2) 처리 2일 : 갈라진 부위가 서서히 아물었다.2)
3) 처리 3일 : 무좀 부위의 각질이 형성되고, 무좀 부위에서의 통증이 사라졌다.3) Treatment 3 days: The keratin of the athlete's foot area was formed, and the pain in the athlete's foot area disappeared.
4) 처리 4일 : 각질의 형성이 두드러져 완전히 치유된 양상을 보였다.4)
2-2. 무좀이 심하지 않은 사람2-2. Athlete's foot is not severe
1일 2회 처리로도 충분한 각질형성을 유도하여 무좀의 완치가 가능하였다.It was possible to cure athlete's foot by inducing sufficient keratinization even twice a day.
아울러, 본 발명에 따른 항균제 조성물은 천연 식물정유를 사용함에 따라 상기 실험에 있어서 피부에 병반이나 부작용이 관찰되지 않았고, 이에 따라 피부에 무해하다는 것을 확인할 수 있었다.In addition, the antimicrobial composition according to the present invention was found to have no lesions or adverse effects on the skin due to the use of a natural plant essential oil, and thus it was confirmed that it was harmless to the skin.
도 2는 본 발명에 따른 항균제 조성물을 이용하여 제조한 항균 로션제의 보관용기(B)에 관한 것으로서, 상기 보관용기(B)는 수용부(B11)가 형성된 바디(B10)와, 상기 바디(B10) 상부에 나사결합되며, 펌프관(B23)이 삽입될 수 있는 펌프삽입홀(B21)이 형성된 구조를 가지고 있으며, 상기 펌프삽입홀(B21)에는 펌프의 구성요소인 펌프관(B23)이 삽입되어, 수용부(B11)에 구비되는 로션제를 사용자가 손쉽게 토출시킬 수 있도록 이루어진다.The present invention relates to a storage container (B) made of antimicrobial lotion prepared using the antibacterial composition according to the present invention. The storage container (B) comprises a body (B10) And a pump insertion hole B21 through which the pump tube B23 can be inserted is formed in the pump insertion hole B21. The pump tube B23, which is a component of the pump, So that the user can easily dispense the lotion provided in the receiving portion B11.
일반적으로 상기 로션제는 액상형으로 이루어지며, 상기 펌프는 종래의 다양한 분야에서 사용되어 펌핑으로 내부의 액체를 토출할 수 있는 펌프로서 자세한 설명은 생략하도록 한다.In general, the lotion agent is in the form of a liquid, and the pump is used in various conventional fields to pump the liquid inside by pumping, and a detailed description thereof will be omitted.
이러한 보관용기(B)를 사용하는 경우, 상기 수용부(B11)에 구비되는 용매의 점도에 따라 수용부(B11) 내벽면 및 펌프관(B23)에 잔유물이 묻어 있는 경우가 빈번하며, 이는 자원손실의 우려도 있으며, 이러한 용기에 다른 종류의 용매를 투입하는 경우, 용매가 혼합될 수 있는 문제가 발생한다.When such a storage container B is used, residues are frequently present on the wall surface of the storage section B11 and the pump tube B23 depending on the viscosity of the solvent provided in the storage section B11, There is a risk of loss, and when other kinds of solvents are put into such a container, there is a problem that the solvent can be mixed.
따라서 본 발명은 쓸어내림수단(B30)을 구비하여 이를 해결하고자 한다.Therefore, the present invention is intended to solve this problem by providing the scavenging means B30.
또한 펌프관(B23)을 이용하여 펌핑하는 경우, 용매의 잔량이 적을 때 펌프관(B23)이 용매를 빨아드리지 못하는 문제 또한 해결하고자 한다.Further, when pumping is performed using the pump tube B23, the problem that the pump tube B23 does not suck the solvent when the remaining amount of the solvent is small is also solved.
먼저, 용매(본 발명에서의 로션제를 의미한다.)가 얼마 남지 않은 경우에도 펌프관(B23)이 용매를 손쉽게 빨아드릴 수 있도록 하기 위하여, 상기 바디(B10)의 저면, 즉 수용부(B11)에 저면에는 중앙방향으로 하향 경사진 경사부(B12)를 형성하고 있으며, 이에 따라 중력에 의해 자연스럽게 샴푸가 바디(B10) 중앙방향으로 모여 펌프관(B23)이 손쉽게 남아있는 샴푸를 빨아드릴 수 있도록 하며, 특히 상기 펌프관(B23)의 단부에는 뾰족부(B231)가 형성되어 용매의 흡입을 보다 수월하게 하고 있다.In order to allow the pump tube B23 to easily suck the solvent even when the solvent (meaning lotion agent in the present invention) is short, the bottom surface of the body B10, that is, the receiving portion B11 The shampoo is naturally concentrated toward the center of the body B10 by gravity and the pump tube B23 can easily suck the remaining shampoo. In particular, a sharp portion B231 is formed at the end of the pump tube B23 to facilitate the suction of the solvent.
상기 쓸어내림수단(B30)에 대하여 설명하면, 상기 쓸어내림수단(B30)은 수용부(B11)에 구비되어 수용부(B11)의 내벽면 및 펌프관(B23)의 외면에 묻어있는 샴푸를 쓸어내리기 위한 것으로서,The scavenging means B30 is provided in the receiving portion B11 to sweep the shampoo on the inner wall surface of the receiving portion B11 and the outer surface of the pump tube B23 For example,
펌프관(B23)이 관통될 수 있는 링형의 지지링(B31)이 삽입되고, 이 지지링(B31)의 외곽에는 제1 쓸어내림부재(B34)가 구비되어 펌프관(B23)의 내벽면에 밀착되고, 상기 지지링(B31)의 내측에는 제2 쓸어내림부재(B35)가 구비되어 상기 펌프관(B23)의 외면에 밀착되는 구조를 갖는다.A ring-shaped support ring B31 through which the pump tube B23 can pass is inserted and a first sweeping-down member B34 is provided on the outer periphery of the support ring B31, And a second scavenging member B35 is provided on the inner side of the support ring B31 to closely contact the outer surface of the pump tube B23.
이 때 상기 지지링(B31)은 부력이 형성될 수 있도록 내부에 에어가 차 있으며, 실리콘, 플라스틱 등과 같이 중량이 적게 나가는 재질로 이루어지는 것이 바람직하다.At this time, it is preferable that the support ring B31 is made of a material such as silicone, plastic or the like that is small in weight so that buoyancy can be formed.
상기 제1 쓸어내림부재(B34)와 제2 쓸어내림부재(B35)는 모두 고무 또는 실리콘 등의 재질로 이루어져, 탄성을 갖으며, 바디(B10)의 내벽면 및 펌프관(B23)의 외면에 밀착되어 하강하면, 묻어 있는 샴푸를 쓸어내릴 수 있도록 이루어져 있다.The first and second scraping-down members B34 and B35 are made of rubber or silicone and have elasticity. The inner wall surface of the body B10 and the outer surface When it comes close and descends, it is made to be able to sweep away the buried shampoo.
또한 상기 지지링(B31)이 부력을 형성하는 재질로 이루어짐에 따라, 수용부(B11)에 채워지는 샴푸에 떠다닐 수 있도록 하여, 샴푸를 사용하게 되면, 자연스럽게 같이 하강하여 묻어있는 샴푸를 쓸어내릴 수 있으며, 후술하는 제1 마그넷(B31)과 제2 마그넷(B32)의 구성에 의해 사용자가 임의로 샴푸를 쓸어내리는 것도 가능하며, 이에 권리범위를 제한 해석해서는 안 된다.Further, since the support ring B31 is made of a material forming buoyancy, the supporting ring B31 can float on the shampoo which is filled in the receiving portion B11, and when the shampoo is used, the shampoo descends naturally and wipes off the shampoo And the user can arbitrarily sweep the shampoo down by the configuration of the first magnet B31 and the second magnet B32 which will be described later.
다시 상기 지지링(B31)의 외곽, 즉 상기 제1 쓸어내림부재(B34)의 상부에는 상기 지지링(B31)과 연결되는 제1 마그넷(B31)이 구비되어 있으며, 상기 제1 마그넷(B31)과 자성에 의해 결합되는 제2 마그넷(B32)이 상기 바디(B10)의 외면에 부착되게 된다.A first magnet B31 connected to the support ring B31 is provided at the outer periphery of the support ring B31, that is, at an upper portion of the first scavenging member B34, And the second magnet B32 is magnetically coupled to the outer surface of the body B10.
일반적으로 상기 바디(B10)는 블로우 성형을 통해 가공되는 것으로서, 상기 바디(B10)가 제1 마그넷(B31)과 제2 마그넷(B32) 사이에 위치하여도 제1 마그넷(B31)과 제2 마그넷(B32)은 자성에 의해 서로 부착될 수 있으며, 이에 따라 사용자가 제2 마그넷(B32)을 잡고 아래로 하강시키면, 바디(B10) 내부에 있는 지지링(B31)이 제2 마그넷(B32)에 의해 함께 하강하여, 수용부(B11) 내벽면 및 펌프관(B23) 외면에 묻어 있는 샴푸를 아래로 하강시킬 수 있도록 한다.Generally, the body B10 is processed through blow molding. Even if the body B10 is positioned between the first magnet B31 and the second magnet B32, the first magnet B31 and the second magnet B31 The support ring B31 inside the body B10 can be attached to the second magnet B32 by the second magnet B32 and the second magnet B32 can be attached to each other by the magnetism, So that the shampoo on the inner wall surface of the accommodating portion B11 and the outer surface of the pump tube B23 can be lowered downward.
나아가 이러한 쓸어내림수단(B30)은 사용자가 샴푸를 리필하거나 바꿀 때 수용부(B11) 내에서 꺼내야 하는 불편함이 있는데, 이를 개선하기 위하여 본 발명은 뚜껑(B20)의 단부에 금속부재(B36)를 더 구비하여 상기 쓸어내림수단(B30)을 상승시키면 자연스럽게 제2 마그넷(B32)이 상기 금속부재(B36)에 자성에 의해 부착되어 뚜껑(B20)에 부착될 수 있도록 한다.In order to solve this problem, the present invention is characterized in that the metallic member B36 is attached to the end of the lid B20, and the metallic member B36 is attached to the end of the lid B20, The second magnet B32 can be magnetically attached to the metal member B36 and can be attached to the lid B20 by raising the scavenging means B30.
또한 상기 쓸어내림수단(B30)을 동작함에 있어 편의성을 확보하기 위해서는 상기 쓸어내림수단(B30)이 아래로 직진운동을 할 수 있도록 구현되어야 하며, 상기 뚜껑(B20)에 부착된 경우에는 뚜껑(B20)을 분리하는 회전동작과 함께 공회전 가능하게 구비되어야 하는 바,Further, in order to ensure convenience in operating the scraping-down means B30, the scraping-down means B30 must be able to move downward. When the scraping-down means B30 is attached to the lid B20, In order to be able to idle,
이를 위하여 상기 바디(B10)는 외벽부(B112)와, 상기 외벽부(B112)가 형성하는 수용부(B11)의 직경보다 작은 내벽부(B111)로 이루어지며, 상기 내벽부(B111)에 상기 제1 마그넷(B31)이 인입될 수 있는 직선형의 가이드홀(B114)이 구비되게 된다.The body B10 includes an outer wall portion B112 and an inner wall portion B111 that is smaller in diameter than the receiving portion B11 formed by the outer wall portion B112. A linear guide hole B114 through which the first magnet B31 can be inserted is provided.
따라서 상기 쓸어내림수단(B30)이 하강하는 경우에는, 상기 가이드홀(B114)에 제1 마그넷(B31)이 인입되어 가이드홀(B114)을 따라 아래로 직선운동 할 수 있으며, 상기 내벽부(B111)와 외벽부(B112) 사이의 공간(회전유도부(B113))에 쓸어내림수단(B30)이 위치하면(상기 제1 마그넷(B31)이 금속부재(B36)에 부착될 때 상기 회전유도부(B113)에 위치하게 된다.) 뚜껑(B20)의 회전과 함께 상기 쓸어내림수단(B30)이 회전하여 사용자가 손쉽게 탈거 할 수 있도록 이루어진다.The first magnet B31 can be drawn into the guide hole B114 and linearly moved down along the guide hole B114 when the scavenging means B30 descends, (When the first magnet B31 is attached to the metal member B36), when the sweeping-down means B30 is located in the space (the rotation inducing portion B113) between the rotation guide portion B113 and the outer wall portion B112 ) The sweep down unit B30 rotates together with the rotation of the lid B20 so that the user can easily remove the sweep down unit B30.
아울러, 상기 지지링(B31), 제1 쓸어내림부재(B34), 제2 쓸어내림부재(B35)는 링 형상으로 이루어지고, 상기 제1 마그넷(B31)은 상기 지지링(B31)의 양측에 서로 대응되게 구비되는 것이 바람직하다.In addition, the support ring B31, the first scavenging member B34 and the second scavenging member B35 are ring-shaped, and the first magnet B31 is provided on both sides of the support ring B31 It is preferable that they are provided so as to correspond to each other.
또 이상에서 본 발명을 설명함에 있어 첨부된 도면을 참조하여 특정 형상과 구조 및 구성을 갖는 식물 정유를 포함하는 항균제 조성물 및 이를 이용하여 제조된 향균 로션제를 보관하는 보관용기를 위주로 설명하였으나 본 발명은 당업자에 의하여 다양한 수정, 변경 및 치환이 가능하고, 이러한 수정, 변경 및 치환은 본 발명의 보호범위에 속하는 것으로 해석되어야 한다.While the present invention has been described with reference to the accompanying drawings, it is to be understood that the present invention has been described with reference to the antibacterial composition comprising plant essential oil having a specific shape, structure and composition, and a storage container for storing the antiseptic lotion preparation It will be understood by those skilled in the art that various changes, substitutions and substitutions are possible, and that these modifications, alterations, and substitutions are intended to be included within the scope of the present invention.
C : 항균 로션제 B : 보관용기
B10 : 바디 B20 : 뚜껑
B30 : 쓸어내림수단C: Antibacterial lotion B: Storage container
B10: Body B20: Lid
B30: Sweeping means
Claims (4)
코코넛유, 포타슘하이드록사이드, 피마자유, 올리브유, 설탕을 함유하는 순비누;
송진, 황금추출물, 로즈마리추출물, 목련추출물, 멘톨을 포함하는 식물추출첨가물;
씨트로넬라유, 티트리유, 메이창유, 라벤더유, 파인유, 윈터그린유, 벤조인유, 패출리유, 계피유, 레몬유, 회향유, 페파민트유, 그레이후르츠유, 로즈마리유, 유칼립투스유가 함유된 항균정유;
을 포함하여 이루어지되,
항균제 조성물 총 중량을 100중량부로 할 때,
상기 정제수는 52.48 중량부로 이루어지고,
상기 순비누는
코코넛유 11.06 중량부, 포타슘하이드록사이드 3.69중량부, 피마자유 2.57 중량부, 올리브유 1.80 중량부, 설탕 1.54 중량부로 일루어지고,
상기 식물추출첨가물은
송진 0.10 중량부, 황금추출물, 로즈마리추출물, 목련추출물, 멘톨은 각각 0.21 중량부로 이루어지며,
상기 항균정유는
씨트로넬라유 0.08 중량부, 티트리유 1.54 중량부, 메이창유 0.05 중량부, 라벤더유 0.03 중량부, 파인유 0.03 중량부, 윈터그린유 0.01 중량부, 벤조인유 0.01 중량부, 패출리유 0.01 중량부, 계피유 5.14 중량부, 레몬유 2.57 중량부, 회향유 0.26 중량부, 페파민트유 5.14 중량부, 그레이프후르츠유 7.20 중량부, 로즈마리유 0.26 중량부, 유칼립투스유 3.60 중량부로 이루어지는 것을 특징으로 하는 항균제 조성물.Purified water;
Pure soap containing coconut oil, potassium hydroxide, castor oil, olive oil and sugar;
Plant extracts including rosin, gold extract, rosemary extract, magnolia extract, menthol;
Antimicrobial essential oils containing cetronella, tea tree oil, mayo oil, lavender oil, pine oil, wintergreen oil, benzoin oil, fenugreek oil, cinnamon oil, lemon oil, fennel oil, peppermint oil, grapefruit oil, rosemary oil and eucalyptus oil;
, ≪ / RTI >
When the total weight of the antimicrobial composition is 100 parts by weight,
The purified water consisted of 52.48 parts by weight,
The net soap
11.06 parts by weight of coconut oil, 3.69 parts by weight of potassium hydroxide, 2.57 parts by weight of castor oil, 1.80 parts by weight of olive oil, and 1.54 parts by weight of sugar,
The plant extract additive
0.10 part by weight of rosin, 0.21 part by weight of gold extract, rosemary extract, magnolia extract and menthol,
The antimicrobial essential oil
0.03 part by weight of lignan oil, 0.03 part by weight of lavender oil, 0.03 part by weight of lavender oil, 0.01 part by weight of wintergreen oil, 0.01 part by weight of benzoin oil, 0.01 part by weight of peppermint oil, 0.08 part by weight of cetronella, 1.54 parts by weight of tea tree oil, 5.14 parts by weight of cinnamon oil, 2.57 parts by weight of lemon oil, 0.26 parts by weight of fennel oil, 5.14 parts by weight of peppermint oil, 7.20 parts by weight of grapefruit oil, 0.26 part by weight of rosemary oil and 3.60 parts by weight of eucalyptus oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180141666A KR101982697B1 (en) | 2018-11-16 | 2018-11-16 | Antimicrobial components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180141666A KR101982697B1 (en) | 2018-11-16 | 2018-11-16 | Antimicrobial components |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101982697B1 true KR101982697B1 (en) | 2019-05-29 |
Family
ID=66672369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180141666A Active KR101982697B1 (en) | 2018-11-16 | 2018-11-16 | Antimicrobial components |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101982697B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011516504A (en) * | 2008-04-08 | 2011-05-26 | ラボラトワール・エム2 | Disinfectant preparation |
KR101898950B1 (en) * | 2018-07-26 | 2018-10-31 | 정선화 | Foot-shampoo components |
-
2018
- 2018-11-16 KR KR1020180141666A patent/KR101982697B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011516504A (en) * | 2008-04-08 | 2011-05-26 | ラボラトワール・エム2 | Disinfectant preparation |
KR101898950B1 (en) * | 2018-07-26 | 2018-10-31 | 정선화 | Foot-shampoo components |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carson et al. | Antimicrobial activity of the essential oil of Melaleuca alternifolia | |
KR20070079596A (en) | Functional cosmetic composition for the treatment of skin diseases | |
CN105112180B (en) | Natural plants floral type essential oil soap with bacteria resistance function and preparation method thereof | |
JP2008534675A (en) | Antibacterial composition containing natural extract, nanosilver, and natural essential oil | |
KR20070113281A (en) | Antimicrobial Compositions and Methods | |
CA2974166C (en) | Microbicidal oil-in-water dispersion | |
CN106109351B (en) | Sterilization repair cleaning agent, preparation method and application thereof | |
US10765620B2 (en) | Organic foaming soap composition and dispenser | |
CN106619309A (en) | Pet nursing agent and preparation method thereof | |
US11130932B2 (en) | Body and pet wash organic foaming soap composition and dispenser | |
CN107961399A (en) | A kind of water-based body lotion containing complex antimicrobials | |
JP4820662B2 (en) | Fish parasite anthelmintic composition using natural plant extract {Anthelistic composition forfishing parasiticing natural plant tracts} | |
US20050158405A1 (en) | Personal decontaminant | |
CN105030613B (en) | A kind of natural plant essential oils foot lotion of antibacterial fatigue-relieving | |
KR101982697B1 (en) | Antimicrobial components | |
KR101898060B1 (en) | Natural aroma essential oil water soluble composition for humidifier disinfectant and the method of manufaturing the same | |
CN108451799A (en) | A kind of hand sanitizer and preparation method thereof | |
KR101877409B1 (en) | Feminine cleanser composition comprising natural herbs essential having antifungal activity, sterilization and deodorization and process thereof | |
KR20080081633A (en) | Antibacterial Soap Composition | |
CN105154257A (en) | Faint-scent natural plant essential oil soap with bacteriostasis function and preparation method of faint-scent natural plant essential oil soap | |
CN111544353A (en) | Antibacterial oral spray and preparation method thereof | |
CN1194662C (en) | Nim cosmetics series based on active component of nim for daily use and its preparing process | |
Khan et al. | Tea tree essential oil | |
KR20110035497A (en) | Antibacterial soap composition using octagonal fennel | |
RU2811227C1 (en) | Antibacterial hand spray |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20181116 |
|
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20181210 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20181116 Comment text: Patent Application |
|
PA0302 | Request for accelerated examination |
Patent event date: 20181210 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20181116 Patent event code: PA03021R01I Comment text: Patent Application |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190118 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190520 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190521 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20190522 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20220414 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20230306 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20240814 Start annual number: 6 End annual number: 6 |